Established in 2017, the Cancer Interoperability Work Group (C.I.) consists of 90+ medical industry professionals and organizations that are working to take control of our own destiny.
Together, 8 different medical specialties, 4 Non-Profits, 4 Federal Regulatory Agencies, 3 State-Based Regulators, 5 Software Providers, and 3 Research Universities, are unified for the exchanging and regulation of cancer knowledge today for better outcomes and insightful decisions tomorrow.
Medical Specialties Currently Involved:
The Work Group is growing, send us a message to learn more.
The Cancer Interoperability (CI) group intends to promote collaboration across all of the diverse specialties of medicine that are involved in the Diagnosis, Treatment and Research efforts related to the entire longitudinal care pathway and workflow experienced by the Cancer patient.
Our group intends to produce Clinical-Models, FHIR Profiles, IHE Structured Data Capture Forms (SDC) and decision support guidelines and span across, and bridge between, each of these diverse groups of medical professionals.
The group also intends to bring the patient perspective into view as they make their journey through their diagnosis and treatments related to cancer, e.g., a priority will be placed on patient-reported outcomes and assessments
Copyright © 2019 Cancer Interoperability All Rights Reserved.